LSII
LIVE

Serial Number

88393497

Owner

Life Science Institute, Inc.

Attorney

Danielle I. Mattessich

Filing Date

Apr 19, 2019

Add to watchlist:

No watchlists yet
View on USPTO

LSII Trademark

Serial Number: 88393497 • Registration: 6297838

LSII is a trademark filed by Life Science Institute, Inc. on April 19, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Life Science Institute, Inc.

Tokyo 100-0005 , JP

Entity Type: 03

Trademark Details

Filing Date

April 19, 2019

Registration Date

March 23, 2021

Published for Opposition

January 5, 2021

Goods & Services

Cells for medical use; Stem cells for medical use; Pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 23, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 23, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 5, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jan 5, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 16, 2020 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Nov 30, 2020 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Nov 27, 2020 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 23, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 19, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 19, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 30, 2020 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 30, 2020 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 30, 2020 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 30, 2020 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 29, 2020 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 14, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 14, 2020 GNSL
SUSPENSION LETTER WRITTEN
Jan 14, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 9, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 9, 2020 CRFA
ASSIGNED TO LIE
Jan 6, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 12, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 3, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jul 3, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jul 3, 2019 CNRT
ASSIGNED TO EXAMINER
Jun 28, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 6, 2019 NWOS
NEW APPLICATION ENTERED
Apr 23, 2019 NWAP